Tobias Moser

821 total citations
33 papers, 544 citations indexed

About

Tobias Moser is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Tobias Moser has authored 33 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 13 papers in Immunology and 11 papers in Neurology. Recurrent topics in Tobias Moser's work include Multiple Sclerosis Research Studies (18 papers), Immunotherapy and Immune Responses (8 papers) and Peripheral Neuropathies and Disorders (7 papers). Tobias Moser is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Immunotherapy and Immune Responses (8 papers) and Peripheral Neuropathies and Disorders (7 papers). Tobias Moser collaborates with scholars based in Austria, Germany and United Kingdom. Tobias Moser's co-authors include Johann Sellner, Tjalf Ziemssen, Katja Akgün, Undine Proschmann, Kerstin Schwenker, Larissa Hauer, Lara Bieler, Eugen Trinka, Peter Wipfler and Andrea Harrer and has published in prestigious journals such as Neurology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tobias Moser

26 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Moser Austria 11 243 184 141 118 94 33 544
Mariano Marrodán Argentina 14 276 1.1× 80 0.4× 171 1.2× 53 0.4× 91 1.0× 39 570
Maria Grazia Piccinno Italy 10 174 0.7× 161 0.9× 96 0.7× 85 0.7× 58 0.6× 15 471
James K. Sheffield United States 10 384 1.6× 94 0.5× 186 1.3× 113 1.0× 209 2.2× 35 669
Liza Rijvers Netherlands 10 162 0.7× 200 1.1× 49 0.3× 60 0.5× 70 0.7× 13 461
Aaron E. Miller United States 10 381 1.6× 151 0.8× 145 1.0× 117 1.0× 131 1.4× 18 656
Hiroyuki Yahikozawa Japan 15 91 0.4× 107 0.6× 181 1.3× 41 0.3× 184 2.0× 37 571
A. Dufour Italy 13 194 0.8× 215 1.2× 82 0.6× 113 1.0× 92 1.0× 28 515
Bárbara Alonso Spain 14 109 0.4× 262 1.4× 37 0.3× 93 0.8× 109 1.2× 22 527
Yaqing Shu China 12 150 0.6× 99 0.5× 212 1.5× 32 0.3× 111 1.2× 38 515

Countries citing papers authored by Tobias Moser

Since Specialization
Citations

This map shows the geographic impact of Tobias Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Moser more than expected).

Fields of papers citing papers by Tobias Moser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Moser. The network helps show where Tobias Moser may publish in the future.

Co-authorship network of co-authors of Tobias Moser

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Moser. A scholar is included among the top collaborators of Tobias Moser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Moser. Tobias Moser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrer, Andrea, Barbara A. Slade, Hannes Oberkofler, et al.. (2025). Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity. Neurology and Therapy. 14(6). 2583–2604.
2.
Messner, Mark, Janne Cadamuro, Hannes Oberkofler, et al.. (2025). Long-term impact of oral cladribine on humoral immunity in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 18. 4243638363–4243638363.
3.
Moser, Tobias, Michael Khalil, Jens Kühle, et al.. (2025). Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood Biomarkers. International Journal of Molecular Sciences. 26(6). 2629–2629.
4.
Bieler, Lara, Maria M. Gabriel, Wolfgang Hitzl, et al.. (2025). Financial burden of out of pocket nonpharmacological therapies in an Austrian multiple sclerosis cohort. Scientific Reports. 15(1). 9469–9469.
5.
Otto, Ferdinand, et al.. (2024). Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple Sclerosis. Neurology Clinical Practice. 15(1). e200410–e200410.
6.
Otto, Ferdinand, Lara Bieler, Tobias Moser, et al.. (2024). Beyond T cell toxicity – Intrathecal chemokine CXCL13 indicating B cell involvement in immune‐related adverse events following checkpoint inhibition: A two‐case series and literature review. European Journal of Neurology. 31(7). e16279–e16279. 7 indexed citations
7.
Moser, Tobias, Joachim Gruber, Daniel Schwarzenhofer, et al.. (2024). Autoimmune and infectious encephalitis: development of a discriminative tool for early diagnosis and initiation of therapy. Journal of Neurology. 271(12). 7583–7591. 2 indexed citations
8.
Moser, Tobias, Katja Akgün, Kerstin Schwenker, et al.. (2024). Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets. Annals of Clinical and Translational Neurology. 11(2). 450–465. 4 indexed citations
9.
Moser, Tobias, Georg Zimmermann, Thomas Berger, et al.. (2023). Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study. Journal of Neurology. 271(1). 374–385. 2 indexed citations
10.
11.
Pilz, Georg, Peter Wipfler, Andrea Harrer, et al.. (2023). Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study. International Journal of Molecular Sciences. 24(7). 6552–6552. 5 indexed citations
12.
Moser, Tobias, et al.. (2023). Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value (P1-3.006). Neurology. 100(17_supplement_2). 2 indexed citations
13.
Hitzl, Wolfgang, Arabella Buchmann, Michael Khalil, et al.. (2023). Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting. International Journal of Molecular Sciences. 24(4). 4067–4067. 13 indexed citations
14.
Moser, Tobias, Tjalf Ziemssen, & Johann Sellner. (2022). Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety. Wiener Medizinische Wochenschrift. 172(15-16). 365–372. 14 indexed citations
15.
Moser, Tobias, Ciara K. O’Sullivan, Ferdinand Otto, et al.. (2022). Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study. Therapeutic Advances in Neurological Disorders. 15. 4213373180–4213373180. 11 indexed citations
16.
Moser, Tobias, Ciara K. O’Sullivan, Georg Pilz, et al.. (2021). Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy. Biomedicines. 9(11). 1584–1584. 10 indexed citations
17.
Otto, Ferdinand, et al.. (2020). Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype. Multiple Sclerosis and Related Disorders. 42. 102108–102108. 1 indexed citations
18.
Moser, Tobias, et al.. (2020). Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine. Multiple Sclerosis and Related Disorders. 48. 102727–102727. 5 indexed citations
19.
Hauer, Larissa, Martin W. Dünser, Tobias Moser, et al.. (2017). Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis. Frontiers in Immunology. 8. 835–835. 24 indexed citations
20.
Hauer, Larissa, Martin W. Dünser, Tobias Moser, et al.. (2016). Autoimmune Encephalitis at the Neurological Intensive Care Unit: Etiologies, Reasons for Admission and Survival. Neurocritical Care. 27(1). 82–89. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariano Marrodán Breakdown of academic impact, for papers by Maria Grazia Piccinno Breakdown of academic impact, for papers by James K. Sheffield Breakdown of academic impact, for papers by Liza Rijvers Breakdown of academic impact, for papers by Aaron E. Miller Breakdown of academic impact, for papers by Hiroyuki Yahikozawa Breakdown of academic impact, for papers by A. Dufour Breakdown of academic impact, for papers by Bárbara Alonso Breakdown of academic impact, for papers by Yaqing Shu
Rankless by CCL
2026